Literature DB >> 8470688

Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.

S D Pearson1, L A Trissel.   

Abstract

The stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at several temperatures were studied. Triplicate test solutions of (1) minocycline hydrochloride 0.1 mg/mL or rifampin 0.1 mg/mL in 5% dextrose injection or 0.9% sodium chloride injection and (2) minocycline hydrochloride 0.1 mg/mL admixed with rifampin 0.1 mg/mL in 0.9% sodium chloride injection were prepared and stored at various temperatures. Samples were removed at intervals for up to seven days and stored at -70 degrees C until analyzed. Drug concentration was measured by stability-indicating high-performance liquid chromatography. Compatibility was assessed by visual and turbidimetric examination. For the solutions containing the drugs separately, minocycline hydrochloride was stable in both diluents, with the initial concentration declining by 8% at 24 degrees C and 2% at 4 degrees C over seven days. Rifampin was less stable, losing 6-8% of the initial concentration in three days at 4 degrees C and 5-7% in 8 hours and 13-17% in 24 hours at 24 degrees C. There was no change in turbidity in the solutions containing either minocycline hydrochloride or rifampin. The admixture, however, was turbid after 72 hours at 37 degrees C. Minocycline hydrochloride in the admixture was stable for seven days at 24 and 4 degrees C but not for three days at 37 degrees C. The concentration of rifampin decreased 20% in one day at 24 degrees C, 8-10% in three days at 4 degrees C, and 14% in 4 hours and 40% and in 24 hours at 37 degrees C.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470688

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  1 in total

1.  Rifampin-Releasing Triple-Layer Cross-Linked Fresh Water Fish Collagen Sponges as Wound Dressings.

Authors:  Jan Miroslav Hartinger; Peter Lukáč; Mikuláš Mlček; Michaela Popková; Tomáš Suchý; Monika Šupová; Hynek Chlup; Lukáš Horný; Jan Závora; Václava Adámková; Ondřej Slanař; Petr Kozlík; Katarina Molnarova; Eva Honsová; Lukáš Lambert; Tomáš Grus
Journal:  Biomed Res Int       Date:  2020-10-16       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.